Skip to main content
. 2020 Oct 19;3(10):e2015748. doi: 10.1001/jamanetworkopen.2020.15748

Figure 2. Rank-Heat Plot of Multiple Therapies in First-Line Treatment of Patients With Extensive-Stage Small Cell Lung Cancer.

Figure 2.

Each sector is colored according to the surface under the cumulative ranking (SUCRA) value of the corresponding treatment and outcome. The scale consists of 3 colors: red, indicating 0% probability of being ranked first; yellow, indicating 50%; and green, indicating 100%. Uncolored sectors indicate that the treatment was not included in the network meta-analyses for the particular outcome. DCR indicates disease control rate; ORR overall response rate; OS, overall survival; PD-L1, programmed cell death ligand 1; PFS, progression-free survival; and TRAE 3-5, treatment-related adverse event, grades 3 to 5.